Nosso grupo organiza mais de 3.000 Séries de conferências Eventos todos os anos nos EUA, Europa e outros países. Ásia com o apoio de mais 1.000 Sociedades e publica mais de 700 Acesso aberto Periódicos que contém mais de 50.000 personalidades eminentes, cientistas de renome como membros do conselho editorial.

Periódicos de acesso aberto ganhando mais leitores e citações
700 periódicos e 15 milhões de leitores Cada periódico está obtendo mais de 25.000 leitores

Abstrato

Advancements in Soft Tissue Sarcoma Research and Treatment

Paul Colon*

Soft tissue sarcoma (STS) is a rare and diverse group of malignancies originating from soft tissues, presenting significant challenges in diagnosis and treatment. However, recent advancements in STS research and treatment have brought new hope to patients and healthcare professionals alike. This abstract highlights some of the key breakthroughs in STS research and treatment strategies. Genomic profiling has emerged as a critical tool, providing insights into the genetic alterations and molecular pathways driving STS development. By identifying specific gene mutations unique to various subtypes, personalized treatment approaches, including targeted therapies and immunotherapies, have been developed to exploit tumor vulnerabilities effectively.